Coronavirus (COVID-19) News
Filter News
Found 2,643 articles
-
The companies intend to push the vaccine candidate into human trials by April of this year, subject to regulatory approval.
-
The $500,000 gift was in response to the COVID-19 outbreak and a need for more support, testing capacity and advancements.
-
Hospitals and laboratories will be able to run the test on Roche’s fully automated cobas 6800 and cobas 8800 Systems, which are already in wide use in the U.S. and internationally.
-
Under the terms of the agreement, AbCellera and Lilly have committed to equally share initial development costs towards a product, after which Lilly will be responsible for all further development, manufacturing and distribution.
-
Canada’s Medicago announced Thursday it has successfully produced a Virus-Like Particle of the coronavirus just 20 days after obtaining the SARS-CoV-2 gene. The company is now focused on developing a vaccine for COVID-19, the virus caused by SARS-CoV-2.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
More flexible versions of the COVID-19 diagnostic tests are being developed but, currently, are only available for research.
-
Could an arthritis medication show promise as a treatment for the symptoms related to the coronavirus? That’s what Regeneron and Sanofi intend to find out.
-
Numerous organizations are cancelling or postponing activities that involve large groups of people.
-
Gates Foundation and Two Other Major Charities Pledge $125 Million to Jumpstart Coronavirus Treat...
3/10/2020
The Gates Foundation and the Wellcome Trust are contributing up to $50 million each, with the Mastercard Impact Fund offering up to $25 million for initial projects. -
According to reports, 15 employees who attended a management meeting in Boston have now tested positive for the virus.
-
According to a company statement, the three employees are doing well and “improving under the care of their healthcare providers.”
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
The mandatory work-from-home policy will remain in effect through March 31, but could be extended depending on circumstances.
-
As the coronavirus outbreak that causes COVID-19 escalates, biopharma companies and government agents are working quickly to develop and test a vaccine, although most estimates are it will take 12 to 18 months before it could get to market.
-
Biopharma companies, government regulatory and health agencies and academic centers are stepping forward and working to test or develop vaccines and therapeutics for the disease.
-
Multiple pharma conferences set to take place in the United States this month will proceed as planned, but event organizers are urging precaution against the coronavirus.
-
According to a Wall Street Journal report, Takeda has assigned about 40 staffers to work on the project, which was only conceptual a few weeks ago until they triggered the program.
-
Scangos, who currently helms Vir Biotechnology, is expected to coordinate the industry’s response to the increasing coronavirus threat.
-
The novel coronavirus that causes the disease COVID-19 continues to spread and has now been diagnosed in more than 50 countries.